SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?


To: aknahow who wrote (7325)9/25/1998 1:44:00 PM
From: Robert K.  Respond to of 17367
 
I am pretty sure it was a Icaac proceedings story. I also know that this story was "essentially" bpi. Now it might have been another antibiotic,
but story was really close fit. Nothing anywhere on the net that I can see. Like I said, media may pick it up. Just gotta wait and see.
BTW-they did not mention thousands of patients ( I think)
What other antibiotics (like neuprex) are at end stage of human testing that fit neuprex's story regarding resistance?